Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Vanda Pharmaceuticals Inc (NASDAQ: VNDA) closed at $4.61 in the last session, down -0.86% from day before closing price of $4.65. In other words, the price has decreased by -$0.86 from its previous closing price. On the day, 0.67 million shares were traded. VNDA stock price reached its highest trading level at $4.655 during the session, while it also had its lowest trading level at $4.555.
Ratios:
We take a closer look at VNDA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.67 and its Current Ratio is at 4.68. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $11.
On February 25, 2022, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $24 to $12.
On May 12, 2021, BofA Securities started tracking the stock assigning a Buy rating and target price of $22.BofA Securities initiated its Buy rating on May 12, 2021, with a $22 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 29 ’24 when Moran Kevin Patrick sold 2,251 shares for $5.92 per share. The transaction valued at 13,327 led to the insider holds 228,763 shares of the business.
Moran Kevin Patrick bought 2,251 shares of VNDA for $13,327 on Jul 29 ’24. On Mar 05 ’24, another insider, Williams Timothy, who serves as the SVP & General Counsel of the company, sold 8,941 shares for $4.18 each. As a result, the insider received 37,396 and left with 196,825 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VNDA now has a Market Capitalization of 268716000 and an Enterprise Value of -110528984. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.48 while its Price-to-Book (P/B) ratio in mrq is 0.50. Its current Enterprise Value per Revenue stands at -0.607 whereas that against EBITDA is 4.165.
Stock Price History:
Over the past 52 weeks, VNDA has reached a high of $6.75, while it has fallen to a 52-week low of $3.30. The 50-Day Moving Average of the stock is -15.44%, while the 200-Day Moving Average is calculated to be -3.40%.
Shares Statistics:
According to the various share statistics, VNDA traded on average about 685.03K shares per day over the past 3-months and 660930 shares per day over the past 10 days. A total of 57.53M shares are outstanding, with a floating share count of 55.19M. Insiders hold about 5.31% of the company’s shares, while institutions hold 75.43% stake in the company. Shares short for VNDA as of 1724976000 were 3306983 with a Short Ratio of 4.83, compared to 1722384000 on 2782119. Therefore, it implies a Short% of Shares Outstanding of 3306983 and a Short% of Float of 6.859999999999999.
